Myocardial Viability Assessment During Impella Support with 18-Fluorodesoxyglucose PET Imaging
ESC Heart Failure · 2025
DOI: 10.1002/ehf2.15053 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESC Heart Failure, 2025. Verfasst von Luca Baldetti und 12 weiteren Autor:innen. Beteiligte Einrichtung: Cardiac Intensive Care Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy. Hauptthemen laut MEDLINE: Heart-Assist Devices, Positron-Emission Tomography, Fluorodeoxyglucose F18, Myocardium. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Formal assessment of myocardial viability (MV) is challenging in acute myocardial infarction-related cardiogenic shock (AMI-CS) patients receiving Impella mechanical circulatory support, as the cardiac magnetic resonance gold standard technique is not feasible due to the metallic components of the device. 18-fluorodesoxyglucose metabolic myocardial positron emission tomography (18FDG-PET) may represent a valid and feasible alternative to obtain semi-quantitative and objective evidence of MV during Impella support. We hereby report the first series of sequential AMI-CS patients who received 18FDG-PET scanning to assess MV during Impella support to demonstrate the safety and feasibility of this approach. In this cohort no adverse events occurred during 18FDG-PET scans, and all images were of excellent quality. This study provides a pragmatic guidance on how to perform this imaging modality during Impella support and finally confirms the safety and feasibility of this advanced imaging method also in this vulnerable cohort of patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiac Intensive Care Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
- Nuclear Imaging Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
- School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
- Cardiovascular Imaging Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
- Cardiovascualr Research Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
ORCID-Profile: Luca Baldetti
Zitieren
APA
Baldetti, L., Busnardo, E., Pazzanese, V., Ricchetti, G., Barone, G., Sacchi, S., Calvo, F., Gramegna, M., Pieri, M., Ingallina, G., Camici, P. G., Ajello, S., & Scandroglio, A. M. (2025). Myocardial Viability Assessment During Impella Support with 18-Fluorodesoxyglucose PET Imaging. ESC Heart Failure. https://doi.org/10.1002/ehf2.15053
Vancouver
Baldetti L, Busnardo E, Pazzanese V, Ricchetti G, Barone G, Sacchi S, et al. Myocardial Viability Assessment During Impella Support with 18-Fluorodesoxyglucose PET Imaging. ESC Heart Failure. 2025. doi:10.1002/ehf2.15053
BibTeX
@article{Baldetti2025,
author = {Baldetti, Luca and Busnardo, Elena and Pazzanese, Vittorio and Ricchetti, Gianluca and Barone, Giuseppe and Sacchi, Stefania and Calvo, Francesco and Gramegna, Mario and Pieri, Marina and Ingallina, Giacomo and Camici, Paolo Guido and Ajello, Silvia and Scandroglio, Anna Mara},
title = {Myocardial Viability Assessment During Impella Support with 18-Fluorodesoxyglucose PET Imaging},
journal = {ESC Heart Failure},
year = {2025},
doi = {10.1002/ehf2.15053}
}
EUVIMED